“Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis”, Dermatol Pract Concept, vol. 13, no. 4, p. e2023215, Oct. 2023, doi: 10.5826/dpc.1304a215.